{"cell_type":{"2132f89a":"code","7ecb2967":"code","60b0ebdd":"code","511422d1":"code","3a8f68b5":"code","31f7e11f":"code","a46f9b3e":"code","de9358c1":"code","e5483a04":"code","494908e1":"code","7a802d15":"code","91ce4377":"code","199c6f08":"code","dc916c31":"code","62f54e02":"code","ac699dc6":"code","f8ccbf2b":"code","cf1ad2b0":"code","c2095593":"code","2284361d":"code","cbbdad91":"code","6bca3211":"code","f2addd66":"code","7a7f85cb":"code","b288a0a5":"code","583423e3":"code","af3b8600":"code","96f50999":"code","496ca707":"code","c4468009":"code","8ca7ffc1":"code","a8397334":"code","259d6f74":"code","e99d4dc1":"code","05d08d8f":"code","a32ecc56":"code","bd254408":"code","4a203c4d":"code","2de38faa":"code","022210cf":"code","776ab15c":"code","4960ec50":"code","9a569034":"code","2e7071bf":"code","66ee7b57":"code","67ee0282":"code","e4c24f57":"code","cfc33e67":"code","fcdcca58":"code","ec522a40":"code","1ba3428f":"code","d2f6c8d3":"code","d2340695":"code","d67a5595":"code","133d674f":"code","f158f94f":"code","5788c5a2":"code","d2063249":"code","c5f57214":"code","c6bc7483":"code","21ffa623":"code","c2e7d316":"code","b92af602":"code","773f56f5":"code","f0440218":"code","36b8d476":"code","f74451be":"code","531ca131":"code","724fd50f":"code","dd87b0f0":"code","284aba4d":"code","2136a191":"code","e81155b0":"code","556bde56":"code","b4c8d0f0":"code","0ed9856d":"markdown","96677737":"markdown","85121e49":"markdown","b8f64e3d":"markdown","decb5131":"markdown","a65159a4":"markdown","6c2c0a50":"markdown","aa126ffb":"markdown","584f1d43":"markdown","bf81417b":"markdown","ede71938":"markdown","b5839af6":"markdown","10591da8":"markdown","b9c267a3":"markdown","8d29408f":"markdown","1d043975":"markdown","54ccf6a5":"markdown","53d72c55":"markdown","5e1f5611":"markdown","1f7e15f1":"markdown","70643f94":"markdown","adc3f503":"markdown","335220e3":"markdown","1ebc0ef9":"markdown","2934c1a8":"markdown","09826bd3":"markdown","17036aab":"markdown","6de7d112":"markdown","1f589250":"markdown","c6df6305":"markdown","24c0028b":"markdown","3cb96faa":"markdown","393e8e4b":"markdown","ad8601c4":"markdown","8143bc2d":"markdown","89e4b09c":"markdown","5e10533b":"markdown","06c5edb2":"markdown","99689dc6":"markdown","69b5ee15":"markdown","98bed165":"markdown","7dd26dae":"markdown","a396b001":"markdown","b0dce6c6":"markdown","2ac72a7d":"markdown","57444b8b":"markdown","57dd72ea":"markdown","44730cd0":"markdown","2847abdd":"markdown","81238cdf":"markdown","09f56f11":"markdown","972b3e40":"markdown","5bb721ab":"markdown","ac40563f":"markdown","1e583948":"markdown","a33ffa26":"markdown","acc8c332":"markdown","3bcc4d62":"markdown","cce011b0":"markdown","d083ff67":"markdown","bdbc2fed":"markdown","8ccba44f":"markdown","3dc47fae":"markdown"},"source":{"2132f89a":"import pandas as pd\nimport numpy as np\nimport seaborn as sns\nimport matplotlib.pyplot as plt\nimport warnings\nsns.set(rc={'figure.figsize':(20,10),\n            'legend.fontsize': 'x-large'})\nparams = {'legend.fontsize': 'x-large',\n          'figure.figsize': (20, 10),\n         'axes.labelsize': 'x-large',\n         'axes.titlesize':'x-large',\n         'xtick.labelsize':'x-large',\n         'ytick.labelsize':'x-large'}\nplt.rcParams.update(params)\nwarnings.filterwarnings('ignore')","7ecb2967":"data = pd.read_csv(\"..\/input\/heart-failure\/heart_failure_clinical_records_dataset.csv\")","60b0ebdd":"df = data.copy()","511422d1":"df.head()","3a8f68b5":"df.shape","31f7e11f":"df.info()","a46f9b3e":"sns.boxplot(\"creatinine_phosphokinase\",data = df)\nplt.title(\"Kreatinin Fosfokinaz\")\nplt.show()","de9358c1":"df['creatinine_phosphokinase'].describe()","e5483a04":"print(df['creatinine_phosphokinase'].quantile(0.90))","494908e1":"df[\"creatinine_phosphokinase\"] = np.where(df[\"creatinine_phosphokinase\"] >1203.8, 1203.8,df['creatinine_phosphokinase'])","7a802d15":"sns.boxplot(\"creatinine_phosphokinase\",data = df)\nplt.title(\"Kreatin Fosfokinaz\")\nplt.show()","91ce4377":"sns.boxplot(\"ejection_fraction\",data = df)\nplt.title(\"Ejeksiyon Fraksiyonu\")\nplt.show()","199c6f08":"df['ejection_fraction'].describe()","dc916c31":"print(df['ejection_fraction'].quantile(0.99))","62f54e02":"df[\"ejection_fraction\"] = np.where(df[\"ejection_fraction\"] >62.05, 62.05,df['ejection_fraction'])","ac699dc6":"sns.boxplot(\"ejection_fraction\",data = df)\nplt.title(\"Ejeksiyon Fraksiyonu\")\nplt.show()","f8ccbf2b":"sns.boxplot(\"platelets\",data = df)\nplt.title(\"Platelets\")\nplt.show()","cf1ad2b0":"df['platelets'].describe()","c2095593":"print(df['platelets'].quantile(0.95))","2284361d":"print(df['platelets'].quantile(0.03))","cbbdad91":"df[\"platelets\"] = np.where(df[\"platelets\"] >422499.99, 422499.99,df['platelets'])\ndf[\"platelets\"] = np.where(df[\"platelets\"] <118160.0, 118160.0,df['platelets'])","6bca3211":"sns.boxplot(\"platelets\",data = df)\nplt.title(\"Platelets\")\nplt.show()","f2addd66":"sns.boxplot(\"serum_creatinine\",data = df)\nplt.title(\"Serum Kreatinin\")\nplt.show()","7a7f85cb":"df['serum_creatinine'].describe()","b288a0a5":"print(df['serum_creatinine'].quantile(0.90))","583423e3":"df[\"serum_creatinine\"] = np.where(df[\"serum_creatinine\"] >2.1, 2.1,df['serum_creatinine'])","af3b8600":"sns.boxplot(\"serum_creatinine\",data = df)\nplt.title(\"Serum Kreatinin\")\nplt.show()","96f50999":"sns.boxplot(\"serum_sodium\",data = df)\nplt.title(\"Serum Sodyum\")\nplt.show()","496ca707":"df['serum_sodium'].describe()","c4468009":"print(df['serum_sodium'].quantile(0.02))","8ca7ffc1":"df[\"serum_sodium\"] = np.where(df[\"serum_sodium\"] <126.96, 126.96,df['serum_sodium'])","a8397334":"sns.boxplot(\"serum_sodium\",data = df)\nplt.title(\"Serum Sodyum\")\nplt.show()","259d6f74":"sns.boxplot(\"time\",data = df)\nplt.title(\"Hastal\u0131k S\u00fcresi(G\u00fcn Baz\u0131nda)\")\nplt.show()","e99d4dc1":"df['time'].describe()","05d08d8f":"sns.violinplot(x=\"age\", data=df, color=\"orange\")\nplt.title(\"Ya\u015f\")\nplt.show()","a32ecc56":"df[\"age\"].describe()","bd254408":"sns.violinplot(x=\"creatinine_phosphokinase\", data=df, color=\"orange\")\nplt.title(\"Kreatin Fosfokinaz\")\nplt.show()","4a203c4d":"df[\"creatinine_phosphokinase\"].describe()","2de38faa":"sns.violinplot(x=\"ejection_fraction\", data=df, color=\"orange\")\nplt.title(\"Enjeksiyon Fraksiyonu\")\nplt.show()","022210cf":"df[\"ejection_fraction\"].describe()","776ab15c":"sns.violinplot(x=\"platelets\", data=df, color=\"orange\")\nplt.title(\"Platelets\")\nplt.show()","4960ec50":"df[\"platelets\"].describe()","9a569034":"sns.violinplot(x=\"serum_creatinine\", data=df, color=\"orange\")\nplt.title(\"Serum Kreatinin\")\nplt.show()","2e7071bf":"df[\"serum_creatinine\"].describe()","66ee7b57":"sns.violinplot(x=\"serum_sodium\", data=df, color=\"orange\")\nplt.title(\"Serum Sodyum\")\nplt.show()","67ee0282":"df[\"serum_sodium\"].describe()","e4c24f57":"sns.violinplot(x=\"time\", data=df, color=\"orange\")\nplt.title(\"Hastal\u0131k S\u00fcresi(G\u00fcn Baz\u0131nda)\")\nplt.show()","cfc33e67":"df[\"time\"].describe()","fcdcca58":"sns.countplot(x=\"anaemia\", data=df,palette=['#432371',\"#FAAE7B\"])\nplt.title(\"Anemi\")\nplt.show()","ec522a40":"df[\"anaemia\"].value_counts(normalize=True)","1ba3428f":"sns.countplot(x=\"diabetes\", data=df,palette=['#432371',\"#FAAE7B\"])\nplt.title(\"Diyabet\")\nplt.show()","d2f6c8d3":"df[\"diabetes\"].value_counts(normalize=True)","d2340695":"sns.countplot(x=\"high_blood_pressure\", data=df,palette=['#432371',\"#FAAE7B\"])\nplt.title(\"Y\u00fcksek Kan Bas\u0131nc\u0131\")\nplt.show()","d67a5595":"df[\"high_blood_pressure\"].value_counts(normalize=True)","133d674f":"sns.countplot(x=\"sex\", data=df,palette=['#432371',\"#FAAE7B\"])\nplt.title(\"Cinsiyet\")\nplt.show()","f158f94f":"df[\"sex\"].value_counts(normalize=True)","5788c5a2":"sns.countplot(x=\"smoking\", data=df,palette=['#432371',\"#FAAE7B\"])\nplt.title(\"Sigara Kullanma Durumu\")\nplt.show()","d2063249":"df[\"smoking\"].value_counts(normalize=True)","c5f57214":"sns.countplot(x=\"DEATH_EVENT\", data=df,palette=['#432371',\"#FAAE7B\"])\nplt.title(\"\u00d6l\u00fcm Durumu\")\nplt.show()","c6bc7483":"df[\"DEATH_EVENT\"].value_counts(normalize=True)","21ffa623":"sns.countplot(x= \"sex\",hue=\"DEATH_EVENT\",data=df,palette=['#9fd3c7',\"#a75265\"])\nplt.title(\"\u00d6l\u00fcm durumunun cinsiyet ile ili\u015fkisi\")\nplt.show()","c2e7d316":"df.groupby(\"sex\")[\"DEATH_EVENT\"].value_counts(normalize=True)","b92af602":"sns.countplot(x= \"smoking\",hue=\"DEATH_EVENT\",data=df,palette=['#9fd3c7',\"#a75265\"])\nplt.title(\"\u00d6l\u00fcm durumunun sigara kullanma durumu ile ili\u015fkisi\")\nplt.show()","773f56f5":"df.groupby(\"smoking\")[\"DEATH_EVENT\"].value_counts(normalize=True)","f0440218":"sns.countplot(x= \"anaemia\",hue=\"DEATH_EVENT\",data=df,palette=['#9fd3c7',\"#a75265\"])\nplt.title(\"\u00d6l\u00fcm durumunun anemi ile ili\u015fkisi\")\nplt.show()","36b8d476":"df.groupby(\"anaemia\")[\"DEATH_EVENT\"].value_counts(normalize=True)","f74451be":"sns.countplot(x= \"diabetes\",hue=\"DEATH_EVENT\",data=df,palette=['#9fd3c7',\"#a75265\"])\nplt.title(\"\u00d6l\u00fcm durumunun diyabet ile ili\u015fkisi\")\nplt.show()","531ca131":"df.groupby(\"diabetes\")[\"DEATH_EVENT\"].value_counts(normalize=True)","724fd50f":"sns.countplot(x= \"high_blood_pressure\",hue=\"DEATH_EVENT\",data=df,palette=['#9fd3c7',\"#a75265\"])\nplt.title(\"\u00d6l\u00fcm durumunun y\u00fcksek kan bas\u0131nc\u0131 ile ili\u015fkisi\")\nplt.show()","dd87b0f0":"df.groupby(\"high_blood_pressure\")[\"DEATH_EVENT\"].value_counts(normalize=True)","284aba4d":"correlation = df.corr()","2136a191":"sns.heatmap(correlation,annot=True)\nplt.title(\"Korelasyon Analizi\")\nplt.show()","e81155b0":"df.groupby(\"DEATH_EVENT\")[\"time\"].describe()","556bde56":"df.isna().sum()","b4c8d0f0":"df.to_csv('heart_failure_clinical_records_dataset_preprocessed.csv',index=False)","0ed9856d":"- Bu b\u00f6l\u00fcmde ayk\u0131r\u0131 de\u011fer analizi(outlier detection) yap\u0131lacakt\u0131r.\n- Ayk\u0131r\u0131(u\u00e7) de\u011ferleri bask\u0131lama y\u00f6ntemi ile temizlenmesi ama\u00e7lanm\u0131\u015ft\u0131r. Veri kayb\u0131n\u0131n en az olaca\u011f\u0131 \u015fekilde bask\u0131lama yap\u0131lacakt\u0131r.","96677737":"- Diyabet hastal\u0131\u011f\u0131 bulunan ve bulunmayan ki\u015filerin \u00f6l\u00fcm oranlar\u0131 ayn\u0131d\u0131r.\n- Bu durumda \u00f6l\u00fcm sonucunun diyabet hastal\u0131\u011f\u0131 bulunma durumu ile ba\u011flant\u0131s\u0131 yoktur.","85121e49":"##### Hastal\u0131k S\u00fcresi","b8f64e3d":"### \u00d6ZN\u0130TEL\u0130KLER \u00d6ZET B\u0130LG\u0130LER","decb5131":"- Ki\u015filerin %68'i \u00f6lm\u00fc\u015ft\u00fcr. %32'si \u00f6lmemi\u015ftir.","a65159a4":"- Anemi hastal\u0131\u011f\u0131 bulunan ki\u015filerin \u00f6lme oran\u0131 bu hastal\u0131\u011f\u0131 bulundurmayan ki\u015filere g\u00f6re daha y\u00fcksektir. Aradaki fark \u00e7ok y\u00fcksek de\u011fildir fakat yine de daha y\u00fcksek oldu\u011fu s\u00f6ylenebilir.","6c2c0a50":"## \u00d6zniteliklerin Da\u011f\u0131l\u0131m\u0131","aa126ffb":"## Kategorik De\u011fi\u015fkenler \u0130le Hedef De\u011fi\u015fkenin Birlikte G\u00f6rselle\u015ftirilmesi","584f1d43":"(1 de\u011ferindeki g\u00f6zlemler erkek, 0 de\u011ferindeki g\u00f6zlemler kad\u0131n cinsiyetini temsil etti\u011fi d\u00fc\u015f\u00fcn\u00fclerek a\u015fa\u011f\u0131daki yorum yap\u0131lm\u0131\u015ft\u0131r.)\n- Ki\u015filerin %64'\u00fc erkektir. %35'i kad\u0131nd\u0131r.","bf81417b":"- Ki\u015filerin serum sodyum de\u011ferleri 127 ile 148 aras\u0131nda da\u011f\u0131lmaktad\u0131r. Ortalama serum sodyum de\u011feri 136'd\u0131r.","ede71938":"##### Diyabet","b5839af6":"- \u00d6len ve \u00f6lmeyen ki\u015filerin cinsiyet da\u011f\u0131l\u0131mlar\u0131 ayn\u0131d\u0131r.\n- Bu durumda \u00f6l\u00fcm sonucunun cinsiyet ile ba\u011flant\u0131s\u0131 yoktur.","10591da8":"**De\u011fi\u015fkenlerin aralar\u0131ndaki korelasyon ili\u015fkisi:**\n\n- Cinsiyet ile sigara kullanma durumu aras\u0131nda pozitif orta \u015fiddetli ili\u015fki bulunmaktad\u0131r. Cinsiyet kolonunda 1 de\u011ferini alan g\u00f6zlemleri erkek olarak belirlemi\u015ftik. Bu durumda veri setindeki erkeklerin sigara kullanma durumu kad\u0131nlara g\u00f6re daha fazlad\u0131r.\n- Serum kreatinin ile ya\u015f aras\u0131nda pozitif d\u00fc\u015f\u00fck \u015fiddetli ili\u015fki bulunmaktad\u0131r. Ya\u015f artt\u0131k\u00e7a serum kreatinin de\u011feri art\u0131\u015f g\u00f6stermektedir.\n","b9c267a3":"**Ejeksiyon Fraksiyonu**","8d29408f":"##### Cinsiyet","1d043975":"### Say\u0131sal De\u011fi\u015fkenlerin G\u00f6rselle\u015ftirilmesi","54ccf6a5":"##### Anemi","53d72c55":"- Bu \u00e7al\u0131\u015fmada kardiyovask\u00fcler hastal\u0131klar veri seti kullan\u0131lm\u0131\u015ft\u0131r. \n- Bu jupyter kernel'un amac\u0131 yukar\u0131da belirtilen veri seti \u00fczerinde ke\u015fif\u00e7i veri analizi y\u00fcr\u00fctmektir.\n- \u00c7al\u0131\u015fmada kullan\u0131lan veri seti 299 g\u00f6zlem ve 13 \u00f6znitelikten olu\u015fmaktad\u0131r.\n- 13 \u00f6znitelikten 6's\u0131 kategorik, 7'si say\u0131sal bir \u00f6zniteliktir.","5e1f5611":"**Serum Kreatinin**","1f7e15f1":"##### Serum Kreatinin","70643f94":"**Serum Sodyum**","adc3f503":"- Hastal\u0131k s\u00fcresi \u00f6len ki\u015filerde daha azd\u0131r. Bunun sebebi, ki\u015filer \u00f6ld\u00fckleri i\u00e7in hastal\u0131k s\u00fcresi az olmas\u0131ndan kaynaklan\u0131yor olabilir.","335220e3":"### Pearson korelasyonuna g\u00f6re;<br>\n**Hedef de\u011fi\u015fken ile di\u011fer de\u011fi\u015fkenler aras\u0131ndaki korelasyon ili\u015fkisi:**\n- Serum kreatinin ile \u00f6lme durumunun aras\u0131nda pozitif orta \u015fiddetli ili\u015fki bulunmaktad\u0131r. Serum kreatinin de\u011feri artt\u0131k\u00e7a \u00f6lme durumu art\u0131\u015f g\u00f6stermektedir. \n- Ya\u015f ile \u00f6lme durumunun aras\u0131nda pozitif orta \u015fiddetli ili\u015fki bulunmaktad\u0131r. Ya\u015f artt\u0131k\u00e7a \u00f6lme durumu da art\u0131\u015f g\u00f6stermektedir.\n- Serum sodyum ile \u00f6lme durumu aras\u0131nda negatif d\u00fc\u015f\u00fck \u015fiddetli ili\u015fki bulunmaktad\u0131r. Serum sodyum de\u011feri azald\u0131k\u00e7a \u00f6lme durumu art\u0131\u015f g\u00f6stermektedir.\n- Ejeksiyon fraksiyonu ile \u00f6lme durumu aras\u0131nda negatif d\u00fc\u015f\u00fck \u015fiddetli ili\u015fki bulunmaktad\u0131r. Ejeksiyon fraksiyonu de\u011feri azald\u0131k\u00e7a \u00f6lme durumu art\u0131\u015f g\u00f6stermektedir.<br>\n- Hastal\u0131k s\u00fcresi ile \u00f6lme durumu aras\u0131nda negatif g\u00fc\u00e7l\u00fc \u015fiddetli ili\u015fki bulunmaktad\u0131r. <br>","1ebc0ef9":"**Platelets**","2934c1a8":"##### Serum Sodyum","09826bd3":"**Kreatinin Fosfokinaz**","17036aab":"##### Y\u00fcksek Kan Bas\u0131nc\u0131","6de7d112":"## Anomali Kontrol\u00fc","1f589250":"## K\u00fct\u00fcphaneleri Y\u00fckleyelim","c6df6305":"##### \u00d6l\u00fcm Durumu","24c0028b":"- **<font color=red>Age :<\/font> Age**, say\u0131sal bir \u00f6zniteliktir. Ki\u015finin ya\u015f bilgisini tutar. Bar\u0131nd\u0131rd\u0131\u011f\u0131 **eksik de\u011fer say\u0131s\u0131 0**'d\u0131r.\n<br\/><br\/>\n- **<font color=red>Anaemia :<\/font> Anaemia**, kategorik bir \u00f6zniteliktir. Ki\u015finin anemi hastas\u0131 olma durumu hakk\u0131nda bilgi tutar. Bar\u0131nd\u0131rd\u0131\u011f\u0131 **eksik de\u011fer say\u0131s\u0131 0**'d\u0131r.\n<br\/><br\/>\n- **<font color=red>Creatinine_phosphokinase :<\/font> Creatinine_phosphokinase**, say\u0131sal bir \u00f6zniteliktir. Ki\u015finin kreatin fosfokinaz de\u011feri bilgisini tutar. Bar\u0131nd\u0131rd\u0131\u011f\u0131 **eksik de\u011fer say\u0131s\u0131 0**'d\u0131r.\n<br\/><br\/>\n- **<font color=red>Diabetes :<\/font> Diabetes**, kategorik bir \u00f6zniteliktir. Ki\u015finin diyabet hastas\u0131 olma durumu hakk\u0131nda bilgi tutar. Bar\u0131nd\u0131rd\u0131\u011f\u0131 **eksik de\u011fer say\u0131s\u0131 0**'d\u0131r.\n<br\/><br\/>\n- **<font color=red>Ejection_fraction :<\/font> Ejection_fraction**, say\u0131sal bir \u00f6zniteliktir. Ki\u015finin ejeksiyon fraksiyonu de\u011feri bilgisini tutar. Bar\u0131nd\u0131rd\u0131\u011f\u0131 **eksik de\u011fer say\u0131s\u0131 0**'d\u0131r.\n<br\/><br\/>\n- **<font color=red>High_blood_pressure :<\/font> High_blood_pressure**, kategorik bir \u00f6zniteliktir. Ki\u015finin y\u00fcksek kan bas\u0131nc\u0131 hastas\u0131 olma durumu hakk\u0131nda bilgi tutar. Bar\u0131nd\u0131rd\u0131\u011f\u0131 **eksik de\u011fer say\u0131s\u0131 0**'d\u0131r.\n<br\/><br\/>\n- **<font color=red>Platelets :<\/font> Platelets**, say\u0131sal bir \u00f6zniteliktir. Ki\u015finin platelets de\u011feri bilgisini tutar. Bar\u0131nd\u0131rd\u0131\u011f\u0131 **eksik de\u011fer say\u0131s\u0131 0**'d\u0131r.\n<br\/><br\/>\n- **<font color=red>Serum_creatinine :<\/font> Serum_creatinine**, say\u0131sal bir \u00f6zniteliktir. Ki\u015finin serum kreatinin de\u011feri bilgisini tutar. Bar\u0131nd\u0131rd\u0131\u011f\u0131 **eksik de\u011fer say\u0131s\u0131 0**'d\u0131r.\n<br\/><br\/>\n- **<font color=red>Serum_sodium :<\/font> Serum_sodium**, say\u0131sal bir \u00f6zniteliktir. Ki\u015finin serum sodyum de\u011feri bilgisini tutar. Bar\u0131nd\u0131rd\u0131\u011f\u0131 **eksik de\u011fer say\u0131s\u0131 0**'d\u0131r.\n<br\/><br\/>\n- **<font color=red>Sex :<\/font> Sex**, kategorik bir \u00f6zniteliktir. Ki\u015finin cinsiyet bilgisini tutar. Bar\u0131nd\u0131rd\u0131\u011f\u0131 **eksik de\u011fer say\u0131s\u0131 0**'d\u0131r.\n<br\/><br\/>\n- **<font color=red>Smoking :<\/font> Smoking**, kategorik bir \u00f6zniteliktir. Ki\u015finin sigara kullanma durumu bilgisini tutar. Bar\u0131nd\u0131rd\u0131\u011f\u0131 **eksik de\u011fer say\u0131s\u0131 0**'d\u0131r.\n<br\/><br\/>\n- **<font color=red>Time :<\/font> Time**, say\u0131sal bir \u00f6zniteliktir. Ki\u015finin hasta oldu\u011fu periyot bilgisini g\u00fcn baz\u0131nda tutar. Bar\u0131nd\u0131rd\u0131\u011f\u0131 **eksik de\u011fer say\u0131s\u0131 0**'d\u0131r.\n<br\/><br\/>\n- **<font color=red>DEATH_EVENT :<\/font> DEATH_EVENT**, kategorik bir \u00f6zniteliktir. Ki\u015finin \u00f6lme durumu bilgisini tutar. Bar\u0131nd\u0131rd\u0131\u011f\u0131 **eksik de\u011fer say\u0131s\u0131 0**'d\u0131r.\n<br\/><br\/>\n","3cb96faa":"#### \u00d6l\u00fcm Durumunun Anemi \u0130le \u0130li\u015fkisi","393e8e4b":"## Korelasyon Analizi","ad8601c4":"#### \u00d6l\u00fcm Durumunun Sigara Kullanma Durumu \u0130le \u0130li\u015fkisi","8143bc2d":"**Yukar\u0131daki durumlar\u0131 \u00f6zetleyecek olursak; ki\u015finin serum kreatinin, ya\u015f \u00f6zniteliklerinin de\u011feri \u00f6lme durumu ile pozitif y\u00f6nde ili\u015fkilidir. Bu \u00f6zniteliklerin de\u011ferleri artt\u0131k\u00e7a \u00f6lme olas\u0131l\u0131\u011f\u0131 art\u0131\u015f g\u00f6stermektedir.**<br>\n**Serum sodyum ve ejeksiyon fraksiyonu \u00f6zniteliklerinin de\u011feri \u00f6lme durumu ile negatif y\u00f6nde ili\u015fkilidir. Bu \u00f6zniteliklerin de\u011ferleri artt\u0131k\u00e7a \u00f6lme olas\u0131l\u0131\u011f\u0131 azal\u0131\u015f g\u00f6stermektedir.**","89e4b09c":"#### \u00d6l\u00fcm Durumunun Y\u00fcksek Kan Bas\u0131nc\u0131 \u0130le \u0130li\u015fkisi","5e10533b":"#### \u00d6l\u00fcm Durumunun Cinsiyet \u0130le \u0130li\u015fkisi","06c5edb2":"- Ya\u015f aral\u0131\u011f\u0131 40 ile 95 aras\u0131nda da\u011f\u0131lmaktad\u0131r. Ya\u015f ortalamas\u0131 60't\u0131r. ","99689dc6":"- Hi\u00e7 bir \u00f6znitelikte eksik de\u011fer bulunmamaktad\u0131r.","69b5ee15":"- Ki\u015filerin kreatinin fosfokinaz de\u011ferleri 23 ile 1203 aras\u0131nda da\u011f\u0131lmaktad\u0131r. Ortalama kreatinin fosfokinaz de\u011feri 416'd\u0131r. ","98bed165":"- Y\u00fcksek kan bas\u0131nc\u0131 hastal\u0131\u011f\u0131 bulunan ki\u015filerin \u00f6lme oran\u0131 bu hastal\u0131\u011f\u0131 bulundurmayan ki\u015filere g\u00f6re daha y\u00fcksektir. Aradaki fark \u00e7ok y\u00fcksek de\u011fildir fakat yine de daha y\u00fcksek oldu\u011fu s\u00f6ylenebilir.","7dd26dae":"##### Kreatinin Fosfokinaz","a396b001":"##### Sigara Kullanma Durumu","b0dce6c6":"- Ki\u015filerin platelets de\u011ferleri 118160 ile 422499 aras\u0131nda da\u011f\u0131lmaktad\u0131r. Ortalama platelets de\u011feri 259464't\u00fcr","2ac72a7d":"## Eksik Veri Kontrol\u00fc","57444b8b":"#### Hedef De\u011fi\u015fkenin G\u00f6rselle\u015ftirilmesi","57dd72ea":"##### Ejeksiyon fraksiyonu","44730cd0":"- Ki\u015filerin %67'si sigara kullanmamaktad\u0131r. %32'si sigara kullanmaktad\u0131r.","2847abdd":"#### \u00d6l\u00fcm Durumunun Diyabet \u0130le \u0130li\u015fkisi","81238cdf":"- Ki\u015filerin ejeksiyon fraksiyonu de\u011ferleri 14 ile 62 aras\u0131nda da\u011f\u0131lmaktad\u0131r. Ortalama ejeksiyon fraksiyonu de\u011feri 38'dir.","09f56f11":"**Hastal\u0131k S\u00fcresi**","972b3e40":"##### Ya\u015f","5bb721ab":"- Ki\u015filerin %56's\u0131nda anemi hastal\u0131\u011f\u0131 g\u00f6r\u00fclmemektedir. %43'\u00fcnde anemi hastal\u0131\u011f\u0131 g\u00f6r\u00fclmektedir.","ac40563f":"- \u00d6zniteliklerin aralar\u0131nda 1'e yak\u0131n veya -1'e yak\u0131n ili\u015fki bulunmamaktad\u0131r. B\u00f6yle bir ili\u015fki g\u00f6zlemlenmi\u015f olsa idi 2 \u00f6znitelikten birisi \u00e7\u0131kar\u0131labilirdi. Fakat b\u00f6yle bir durum s\u00f6z konusu olmad\u0131\u011f\u0131 i\u00e7in \u00f6znitelik eksiltmiyoruz.","1e583948":"### Kategorik De\u011fi\u015fkenlerin G\u00f6rselle\u015ftirilmesi","a33ffa26":"#### Veri Setini D\u0131\u015far\u0131 Aktarma","acc8c332":"- Ki\u015filerin hastal\u0131k s\u00fcresi 4 g\u00fcn ile 285 g\u00fcn aras\u0131nda da\u011f\u0131lmaktad\u0131r. Ortalama hastal\u0131k s\u00fcresi 130 g\u00fcnd\u00fcr. Ki\u015filer \u00e7o\u011funlukla 100 g\u00fcn ve 200 g\u00fcn yak\u0131nlar\u0131nda hastal\u0131k s\u00fcreci ge\u00e7irmi\u015flerdir.","3bcc4d62":"##### Platelets","cce011b0":"# Kardiyovask\u00fcler Hastal\u0131k V1.0\n# Ke\u015fif\u00e7i Veri Analizi","d083ff67":"- \u00d6len ve \u00f6lmeyen ki\u015filerin sigara kullanma oranlar\u0131 yakla\u015f\u0131k ayn\u0131d\u0131r.\n- Bu durumda \u00f6l\u00fcm sonucunun sigara kullanma durumu ile ba\u011flant\u0131s\u0131 yoktur.","bdbc2fed":"- Ki\u015filerin %64'\u00fcndede y\u00fcksek kan bas\u0131nc\u0131 hastal\u0131\u011f\u0131 g\u00f6r\u00fclmemektedir. %35'inde y\u00fcksek kan bas\u0131nc\u0131 hastal\u0131\u011f\u0131 g\u00f6r\u00fclmektedir.","8ccba44f":"- Ki\u015filerin serum kreatinin de\u011ferleri 0.5 ile 2.1 aras\u0131nda da\u011f\u0131lmaktad\u0131r. Ortalama serum kreatinin de\u011feri 1.22'dir.","3dc47fae":"- Ki\u015filerin %58'sinde diyabet hastal\u0131\u011f\u0131 g\u00f6r\u00fclmemektedir. %41'inde diyabet hastal\u0131\u011f\u0131 g\u00f6r\u00fclmektedir."}}